{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:13:11Z","timestamp":1773083591010,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.virusres.2005.05.002","type":"journal-article","created":{"date-parts":[[2005,6,23]],"date-time":"2005-06-23T11:21:43Z","timestamp":1119525703000},"page":"143-152","source":"Crossref","is-referenced-by-count":21,"title":["DNA vaccine for rabies: Relevance of the trans-membrane domain of the glycoprotein in generating an antibody response"],"prefix":"10.1016","volume":"113","author":[{"given":"Archana","family":"Rath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeeta","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.V.","family":"Kapre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2005.05.002_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0264-410X(97)00204-1","article-title":"DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses","volume":"16","author":"Bahloul","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0264-410X(96)00265-4","article-title":"Biological features of genetic immunization","volume":"15","author":"Barry","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib3","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1089\/104303401753153965","article-title":"Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine","volume":"12","author":"Biswas","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virusres.2005.05.002_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1099\/0022-1317-72-2-359","article-title":"Stable expression of rabies virus glycoprotein in Chinese hamster ovary cells","volume":"72","author":"Burger","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2005.05.002_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.16.3.754-759.1977","article-title":"Rabies virus glycoprotein II. Biological and serological characterization","volume":"16","author":"Cox","year":"1977","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virusres.2005.05.002_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-1702(02)00267-8","article-title":"Differential stability and fusion activity of Lyssavirus glycoprotein trimers","volume":"91","author":"Desmezieres","year":"2003","journal-title":"Virus Res."},{"key":"10.1016\/j.virusres.2005.05.002_bib7","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0264-410X(98)00357-0","article-title":"Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?","volume":"17","author":"Drings","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0378-1119(96)00194-1","article-title":"Expression of genes encoding two major Theileria annulata merozoite surface antigens in Escherichia coli and a Salmonella typhimurium aroA vaccine strain","volume":"172","author":"d\u2019Oliveira","year":"1996","journal-title":"Gene"},{"key":"10.1016\/j.virusres.2005.05.002_bib9","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1073\/pnas.90.24.11478","article-title":"DNA vaccines: Protective immunization by parentral, mucosal, and gene-gun inoculations","volume":"90","author":"Fynan","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virusres.2005.05.002_bib10","first-page":"389","article-title":"Glycosylation of zona pellucida glycoprotein-3 is required for inducing acrosomal exocytosis in the bonnet monkey","volume":"49","author":"Gahlay","year":"2003","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.virusres.2005.05.002_bib11","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1099\/0022-1317-80-7-1647","article-title":"Soluble ectodomain of rabies virus glycoprotein expressed in eukaryotic cells folds in a monomeric conformation that is antigenically distinct from the native state of the complete, membrane-anchored glycoprotein","volume":"80","author":"Gaudin","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2005.05.002_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","article-title":"Chimeric lyssavirus glycoproteins with increased immunological potential","volume":"73","author":"Jallet","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.virusres.2005.05.002_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1098-2795(199706)47:2<140::AID-MRD3>3.0.CO;2-M","article-title":"Expression of bonnet monkey (Macaca radiata) zona pellucida-3 (ZP3) in a prokaryotic system and its immunogenicity","volume":"47","author":"Kaul","year":"1997","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.virusres.2005.05.002_bib14","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/S0264-410X(00)00475-8","article-title":"Post-exposure DNA vaccination protects mice against rabies virus","volume":"19","author":"Lodmell","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0264-410X(01)00392-9","article-title":"One-time gene gun or intra-muscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination","volume":"20","author":"Lodmell","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib16","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1016\/S0264-410X(03)00297-4","article-title":"Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody","volume":"21","author":"Lodmell","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm0898-949","article-title":"DNA immunization protects non-human primates against rabies virus","volume":"4","author":"Lodmell","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2005.05.002_bib18","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0264-410X(99)00352-7","article-title":"DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL)","volume":"18","author":"Lodmell","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib19","series-title":"Lyssaviruses","first-page":"1","article-title":"Rationale and prospects for rabies elimination in developing countries","author":"Meslin","year":"1994"},{"key":"10.1016\/j.virusres.2005.05.002_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1099\/0022-1317-73-2-335","article-title":"Comparison of rabies virus G proteins produced by cDNA-transfected animal cells that display either inducible or constitutive expression of the gene","volume":"73","author":"Morimoto","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2005.05.002_bib21","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/S0264-410X(03)00036-7","article-title":"A comparison of DNA vaccines for the rabies-related virus, Mokola","volume":"21","author":"Nel","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0264-410X(98)00328-4","article-title":"Immunization of dogs and cats with a DNA vaccine against rabies virus","volume":"17","author":"Osorio","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0264-410X(99)00247-9","article-title":"Immunization of dogs with a DNA vaccine induces protection against rabies virus","volume":"18","author":"Perrin","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cellimm.2003.08.006","article-title":"Chemokines and TRANCE as genetic adjuvants for a DNA vaccine to rabies virus","volume":"224","author":"Pinto","year":"2003","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.virusres.2005.05.002_bib25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0042-6822(89)90551-5","article-title":"Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors","volume":"173","author":"Prehaud","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2005.05.002_bib26","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/S0264-410X(02)00824-1","article-title":"Characterization of immune response in mice to plasmid DNA encoding dog zona pellucida glycoprotein-3","volume":"21","author":"Rath","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib27","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0264-410X(96)00281-2","article-title":"Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection","volume":"15","author":"Ray","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.05.002_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1473-3099(02)00287-6","article-title":"Rabies re-examined","volume":"2","author":"Rupprecht","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virusres.2005.05.002_bib29","series-title":"Laboratory Techniques in Rabies","first-page":"181","article-title":"A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody","author":"Smith","year":"1996"},{"key":"10.1016\/j.virusres.2005.05.002_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2005.05.002_bib31","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1021\/bi00008a026","article-title":"Stable secretion of a soluble, oligomeric form of rabies virus glycoprotein: influence of N-glycan processing on secretion","volume":"28","author":"Wojczyk","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.virusres.2005.05.002_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/viro.1995.1289","article-title":"Immune responses to nucleic acid vaccines to rabies virus","volume":"209","author":"Xiang","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2005.05.002_bib33","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1126\/science.6297004","article-title":"Rabies virus glycoprotein analogs: biosynthesis in Escherichia coli","volume":"219","author":"Yelverton","year":"1983","journal-title":"Science"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170205001619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170205001619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T13:33:12Z","timestamp":1683120792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170205001619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0168170205001619"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2005.05.002","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}